Abstract
Nanoparticles (NPs) have been recognized as both useful tools and potentially toxic materials in various industrial and medicinal fields. Previously, we found that zinc oxide (ZnO) NPs that are neurotoxic to human dopaminergic neuroblastoma SH-SY5Y cells are mediated by lipoxygenase (LOX), not cyclooxygenase-2 (COX-2). Here, we examined whether human bone marrow-derived mesenchymal stem cells (MSCs), which are different from neuroblastoma cells, might exhibit COX-2- and/or LOX-dependent cytotoxicity of ZnO NPs. Additionally, changes in annexin V expression, caspase-3/7 activity, and mitochondrial membrane potential (MMP) induced by ZnO NPs and ZnO were compared at 12 hr and 24 hr after exposure using flow cytometry. Cytotoxicity was measured based on lactate dehydrogenase activity and confirmed by trypan blue staining. Rescue studies were executed using zinc or iron chelators. ZnO NPs and ZnO showed similar dose-dependent and significant cytotoxic effects at concentrations ≥ 15 μg/mL, in accordance with annexin V expression, caspase-3/7 activity, and MMP results. Human MSCs exhibited both COX-2 and LOX-mediated cytotoxicity after exposure to ZnO NPs, which was different from human neuroblastoma cells. Zinc and iron chelators significantly attenuated ZnO NPs-induced toxicity. Conclusively, these results suggest that ZnO NPs exhibit both COX-2- and LOX-mediated apoptosis by the participation of mitochondrial dysfunction in human MSC cultures.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Navya, P.N. and Daima, H.K. (2016) Rational engineering of physicochemical properties of nanomaterials for biochemical applications with nanotoxicological perspectives. Nano. Converg., 3, 1–14.
Wu, T. and Tang, M. (2018) Review of the effects of manufactured nanoparticles on mammalian target organs. J. Appl. Toxicol., 38, 25–40.
Dineley, K.E., Votyakova, T.V. and Reynolds, I.J. (2003) Zinc inhibition of cellular energy production: implication for mitochondria and neurodegeneration. J. Neurochem., 85, 563–570.
Capasso, M., Jeng, J.M., Malavolta, M., Mocchegiani, E. and Sensi, S.L. (2005) Zinc dyshomeostasis: a key modulator of neuronal injury. J. Alzheimers Dis., 8, 93–108.
Manzoor, U., Siddique, S., Ahmed, R., Noreen, Z., Bokhari, H. and Ahmed, I. (2016) Antibacterial, structural and optical characterization of mechano-chemically prepared ZnO nanoparticles. PLoS ONE, 11, e0154704.
Sardella, D., Gatt, R. and Valdramidis, V.P. (2017) Physiological effects and mode of action of ZnO nanoparticles against postharvest fungal contaminants. Food Res. Int., 101, 274–279.
Hosseini, M., Fotouhi, L., Ehsani, A. and Naseri, M. (2017) Enhancement of corrosion resistance of polypyrrole using metal oxide nanoparticles: potentiodynamic and electrochemical impedance spectroscopy study. J. Colloid Interface Sci., 505, 213–219.
Kim, Y.H., Kwak, K.A., Kim, T.S., Seok, J.H., Roh, H.S., Lee, J.K., Jeong, J., Meang, E.H., Hong, J.S., Lee, Y.S. and Kang, J.S. (2015) Retinopathy induced by zinc oxide nanoparticles in rats assessed by micro-computed tomography and histopathology. Toxicol. Res., 31, 157–163.
Kim, K.B., Kim, Y.W., Lim, S.K., Roh, T.H., Bang, D.Y., Choi, S.M., Lim, D.S., Kim, Y.J., Baek, S.H., Kim, M.K., Seo, H.S., Kim, M.H., Kim, H.S., Lee, J.Y., Kacew, S. and Lee, B.M. (2017) Risk assessment of zinc oxide, a cosmetic ingredient used as a UV filter of sunscreens. J. Toxicol. Environ. Health B Crit. Rev., 20, 155–182.
Kao, Y.Y., Cheng, T.J., Yang, D.M., Wang, C.T., Chiung, Y.M. and Liu, P.S. (2012) Demonstration of an olfactory bulb-brain translocation pathway for ZnO nanoparticles in rodent cells in vitro and in vivo. J. Mol. Neurosci., 48, 464–471.
Tian, L., Lin, B., Wu, L., Li, K., Liu, H., Yan, J., Liu, X. and Xi, Z. (2015) Neurotoxicity induced by zinc oxide nanoparticles: age-related differences and interaction. Sci. Rep., 5, 16117–16129.
Kim, J.H., Jeong, M.S., Kim, D.Y., Her, S. and Wie, M.B. (2015) Zinc oxide nanoparticles induce lipoxygenase-mediated apoptosis and necrosis in human neuroblastoma SHSY5Y cells. Neurochem. Int., 90, 204–214.
Heim, J., Felder, E., Tahir, M.N., Kaltbeizel, A., Heinrich, U.R., Brochhausen, C., Mailander, V., Tremel, W. and Brieger, J. (2015) Genotoxic effects of zinc oxide nanoparticles. Nanoscale, 7, 8931–8938.
Song, W., Zhang, J., Guo, J., Zhang, J., Ding, F., Li, L. and Sun, Z. (2010) Role of the dissolved zinc ion and reactive oxygen species in cytotoxicity of ZnO nanoparticles. Toxicol. Lett., 199, 389–397.
Mohr, A. and Zwacka, R. (2018) The future of mesenchymal stem cell-based therapeutic approaches for cancer-From cells to ghosts. Cancer Lett., 414, 239–249.
Spees, J.L., Lee, R.H. and Gregory, C.A. (2016) Mechanisms of mesenchymal stem/stromal cell function. Stem Cell Res. Ther., 7, 125–138.
Koh, J.Y. and Choi, D.W. (1987) Quantitative determination of glutamate-mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay. J. Neurosci. Methods, 20, 83–90.
van Rossum, G.S., Bijvelt, J.J., van den Bosch, H., Verkleij, A.J. and Boonstra, J. (2002) Cytosolic phospholipase A2 and lipoxygenase are involved in cell cycle progression in neuroblastoma cells. Cell Mol. Life Sci., 59, 181–188.
Zhang, Y., Aizenman, E., DeFranco, D.B. and Rosenberg, P.A. (2007) Intracellular zinc release, 12-lipoxygenase activation and MAPK dependent neuronal and oligodendroglial death. Mol. Med., 13, 350–355.
Deng, X., Luan, Q., Chen, W., Wang, Y., Wu, M., Zhang, H. and Jiao, Z. (2009) Nanosized zinc oxide particles induce neural stem cell apoptosis. Nanotechnology, 20, 115101.
Wang, J., Deng, X., Zhang, F., Chen, D. and Ding, W. (2014) ZnO nanoparticle-induced oxidative stress triggers apoptosis by activating JNK signaling pathway in cultured primary astrocyte. Nanoscale Res. Lett., 9, 117–129.
Yu, K.N., Yoon, T.J., Minai-Tehrani, A., Kim, J.E., Park, S.J., Jeong, M.S., Ha, S.W., Lee, J.K., Kim, J.S. and Cho, M.H. (2013) Zinc oxide nanoparticle induced autophagic cell death and mitochondrial damage via reactive oxygen species generation. Toxicol. In Vitro, 27, 1187–1195.
Armstrong, C., Leong, W. and Lees, G.J. (2001) Comparative effects of metal chelating agents on the neuronal cytotoxicity by copper (Cu2+), iron (Fe3+) and zinc in the hippocampus. Brian Res., 892, 51–62.
Sharma, V., Anderson, D. and Dhawan, A. (2012) Zinc oxide nanoparticles induce oxidative DNA damage and ROS-triggered mitochondria mediated apoptosis in human liver cells (HepG2). Apoptosis, 17, 852–870.
Liu, G., Men, P., Perry, G. and Smith, M.A. (2010) Nanoparticle and iron chelators as a potential novel Alzheimer therapy. Methods Mol. Biol., 610, 123–144.
Wang, N., Jin, X., Guo, D., Tong, G. and Zhu, X. (2017) Iron chelation nanoparticles with delayed saturation as an effective therapy for Parkinson Disease. Biomacromolecules, 18, 461–474.
Ickrath, P., Wagner, M., Scherzad, A., Burgahartz, M., Hagen, R., Kleinsasser, N. and Hackenberg, S. (2017) Time-dependent toxic and genotoxic effects of zinc oxide nanoparticles after long-term and repetitive exposure to human mesenchymal stem cells. Int. J. Environ. Res. Public Health, 14, E1590.
Syama, S., Sreekanth, P.J., Varma, H.K. and Mohanan, P.V. (2014) Zinc oxide nanoparticles induced oxidative stress in mouse bone marrow mesenchymal stem cells. Toxicol. Mech. Methods, 24, 644–653.
Zhang, X., Li, W. and Yang, Z. (2015) Toxicology of nanosized titanium oxide: an update. Arch. Toxicol., 89, 2207–2217.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
About this article
Cite this article
Kim, DY., Kim, JH., Lee, JC. et al. Zinc Oxide Nanoparticles Exhibit Both Cyclooxygenase- and Lipoxygenase-Mediated Apoptosis in Human Bone Marrow-Derived Mesenchymal Stem Cells. Toxicol Res. 35, 83–91 (2019). https://doi.org/10.5487/TR.2019.35.1.083
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.5487/TR.2019.35.1.083